Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Ovarian Neoplasms 2Breast Neoplasms 2Prostatic Neoplasms 1Neuralgia 1Neoplasms 1

Interventions

Pregabalin 5Lidocaine 4Surveys and Questionnaires 3Bupivacaine 3ziconotide 2Transcranial Magnetic Stimulation 2Oxycodone 2Gabapentin 2Capsaicin 2Amitriptyline 2onabotulinum toxin A 1nabiximols 1Yoga 1Vitamin B 6 1Vitamin B 12 1Vinorelbine 1Vincristine 1Transcutaneous Electric Nerve Stimulation 1Thalidomide 1Telmisartan 1Tapentadol 1Spinal Cord Stimulation 1Sodium Chloride 1Saline Solution 1Radiofrequency Ablation 1Plastic Surgery Procedures 1Paclitaxel 1Oxaliplatin 1Morphine 1Methadone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuralgia × Telmisartan × Clear all
NCT05322889 2024-08-28

PrevTel

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP

Phase 2 Completed
35 enrolled
BreastGynecologic

Breast Neoplasms, Neuralgia, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡